Stephanie Carrington | ICR Investor Relations |
Keith Kendall | CEO |
Ken Marshall | Chief Commercial Officer |
Daniel Barber | Chief Strategy and Development Officer |
John Maxwell | CFO |
Lori Braender | General Counsel |
Liana Moussato | Wedbush Securities |
Jason Butler | JMP Securities |
Good afternoon and welcome to Aquestive Therapeutics Third Quarter 2018 Conference Call. At this time all participants on a listen-only mode. Later, there will be a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this call will be recorded. I would now like to introduce your host for today's conference Miss Stephanie Carrington, ICR Investor Relations.